Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Non-Current Deferred Tax Liability (2016 - 2025)

Haemonetics (HAE) has 16 years of Non-Current Deferred Tax Liability data on record, last reported at $56.0 million in Q4 2025.

  • For Q4 2025, Non-Current Deferred Tax Liability fell 8.9% year-over-year to $56.0 million; the TTM value through Dec 2025 reached $56.0 million, down 8.9%, while the annual FY2025 figure was $62.6 million, 58.26% down from the prior year.
  • Non-Current Deferred Tax Liability reached $56.0 million in Q4 2025 per HAE's latest filing, down from $58.2 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $149.9 million in Q1 2024 and bottomed at $24.3 million in Q3 2021.
  • Average Non-Current Deferred Tax Liability over 5 years is $57.3 million, with a median of $57.1 million recorded in 2025.
  • Peak YoY movement for Non-Current Deferred Tax Liability: plummeted 62.1% in 2023, then skyrocketed 314.23% in 2024.
  • A 5-year view of Non-Current Deferred Tax Liability shows it stood at $24.6 million in 2021, then surged by 63.39% to $40.2 million in 2022, then skyrocketed by 55.03% to $62.2 million in 2023, then dropped by 1.28% to $61.5 million in 2024, then dropped by 8.9% to $56.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non-Current Deferred Tax Liability were $56.0 million in Q4 2025, $58.2 million in Q3 2025, and $59.5 million in Q2 2025.